Explore
Kodiak Sciences IncKOD
$100.73-0.04%24H
KOD / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$6.87B
EPS-4.19
52 Week Range$18.14 - $112.31
Volume$107.88M
Liquidity Score—
About Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing, and marketing therapies to treat retinal diseases in the United States and international markets. The company is headquartered in Palo Alto, California.

Websitekodiak.com
HeadquartersPALO ALTO, CA

Buy

—
—

Assets

Asset
Kodiak Sciences
rKOD
Reality Finance
Trending
SPY
SPDR S&P 500 ETF Trust
$739.950.01%
Details
NVDA
NVIDIA Corporation
$155.590.36%
Details
QQQ
Invesco QQQ Trust Series 1
$662.370.08%
Details

Help